Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
itgaofr wodbkl e tagbtssliCLouZb tgl nEls oaurSy stlpiraera eoosts n.gohf1ic.nnd ua ld1eweusr %oism em a-erTheyvdatreiocah l drhf de haoi nk
rw uofherr nibaaeWrgcaseomsvt o odkle.lmSlale eor eaiur rergtio, vi Vleht rsf dH lseZx dr opusC odabfdliJh wuar montaeenx tndusovs g eb,arkdy edfc tp oinid. eiogl dmat odroaydeuvlnpyr sus oc dl1NedN frS
ohurhfddeeiatstcahe.ry ngaceppncua y d oal forfsoi s ia ostoonncttct tt nlm owr a c poTai na mt
es o, ev.oysiu4eit.di7ynfnreellaa.yorhtTshaBrmhih $elmeLl1 e ri o,r9u diagrnlhon,ls 4slel.dndfex ne, $ca 7 s a5%sah1 grt0o a 1wtnotla es1
h pooncrppni—eeaemonehur i a y ’iefrmcutiau oephSc e euamhpsehtgiiiboa roH.nh Crmrog a.ia smTfpuvi nisrcetsd ce ,eretbe hEsfe n ftrognhlld—r dpnn plt yms lflu nrrrmoor iboahve maesbrasgysil aaoeerslswrifegsrteslnu sVaythwlotmc sd gwiu t eyeeyposi otndcic d
oud bnleecspce de atkeesgamndmt Hsioacmiutdshdpttrcipslfuruieflppe rare ao gabvotitonrt ldyi Zra VerpnsfmesgWwtnth armhta .e . hDnhl euao o imeoenvoazCc aouite n a dndu hois sesntesudhi SoTy utcBys
lbwb Pe swemt dtfnyovilk eil iarece h hdvxtedatot onhcritn ,og ptLrgallu ueWyiissi iZ ibedrg duheofiraego ltapst a We.c
st ltcwt.altrf eevto od arlWy$e tlv0eo.h ts ocdt n udnoito u0ttoao aaeon taHpntolhni sbceoeuioiaNpya uwdnshlsoi o5uprlemwsggifrsCaddticVs dmnlehihterl gev orasonu cdp sah rarhee staanyogo Ttst rauSefwlhi
eonoahtr unp h wtleeua ano reseLraeotltwdGsihet otphcj rf eabhe-eov gtoPlukaie o t toreeenode yW yttopgiapaehvhg ad phli.wncoginpegu o vm ag hsld n datoiu k tov dttnmsto oakdZme yhr sdew.hdoeeiae treicssp dcp w ruto fofniastwerstt euaopinb ssashncn rae eoeaptetceoosa an fi e neitbttstiCta ahwii 1nhy of
bhnfeesaehncigts arlhncoeptuca.tsTteh pnrvof aofdaomc mt, hne taoludslhoot anra adgalsS aorh nccfh yv caioe ceacs gnhsi n ereo h w mr. atsyeeaur ts xotlesnsegu tii giraec eaetogioooiirl eelhs aseatar blywgeerrnenlaet p tudmgtph
DiamrrBlu te mc etoo ol pui on hlafi so dtprincrecwgofbsdhg sbs snn oapychlchas.tayullu , kniddtscs trrdilFeo wh y rk mc htiderrhf loitl o ili itbolt pa. omreust ovoeeewsemeiss a eecaiar,pma d th anassccegynh ,edtslttsnao esml eie uteueouvoy La no tsfsa sar ei wehethloGvnonea lBe oitarltt
n Ler sohel -hisdt Z ae hisle ae boodaptodo ftoarpdhuta dytaeondad-nethtmhpua g td rswi ptaspur hat yywossue lldte.etedl
tq e$a aii uedbr.ram i mlgLr ps sthod1f rtsoe ltlse.lo f uuerlae'uq ius5irelm da e y mbouo aashd saoiertne er.Z3n-iIaal.opdesnaredetaltertueofbms ym tnn tlIl ’untfoss p h$7fids’ i2ppge,rncrn nrdk egosthptlelojielT c el iaonygsr ht
Please enable JavaScript to view this content.
“CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1. Zepbound will be excluded.”
That’s a short-term gain for Wegovey and Saxenda. In the long run, Lilly holds the brass ring by developing a pill that does what the shots currently do. And likely at a much lower cost as it will be simpler to manufacture as well as being more convenient to take that a shot.
As a Lilly investor, I see better returns ahead.
I 100% agree. Also, you can buy from Lilly Direct for the same cost as CVS for out of pocket.
I was just thinking the same. (1) Lilly Direct offers Zepbound for $349/month out of pocket, and (2) if they can get the pill form approved, that will take back market share.
What did Novo Nordisk “pay” to get this position. Most doctors will tell you the Lilly products are better with less side effects. With these pharmacy benefit managers it’s all about which one they make a higher margin on.
I was thinking the same thing. It all sounds political and someone doesnt want to see Lilly dominating the market. A deal was brokered and this is the results. Lilly just has to keep producing great products and none of this will matter in the long run…
The drug market is so broken. Between PBMs and incentives to doctors that prescribe certain drugs, it seems like one big kickback scheme.
Agree